Compare Abbott India with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs WOCKHARDT - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

WOCKHARDT 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA WOCKHARDT ABBOTT INDIA/
WOCKHARDT
 
P/E (TTM) x 49.0 -79.6 - View Chart
P/BV x 15.8 1.8 898.3% View Chart
Dividend Yield % 0.4 0.0 19,841.5%  

Financials

 ABBOTT INDIA   WOCKHARDT
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
WOCKHARDT
Mar-18
ABBOTT INDIA/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs8,8341,012 872.9%   
Low Rs5,458532 1,026.8%   
Sales per share (Unadj.) Rs1,731.1355.9 486.5%  
Earnings per share (Unadj.) Rs211.9-60.3 -351.6%  
Cash flow per share (Unadj.) Rs219.9-46.8 -470.2%  
Dividends per share (Unadj.) Rs65.000.01 650,000.0%  
Dividend yield (eoy) %0.90 70,200.3%  
Book value per share (Unadj.) Rs945.2257.8 366.6%  
Shares outstanding (eoy) m21.25110.63 19.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.12.2 190.3%   
Avg P/E ratio x33.7-12.8 -263.4%  
P/CF ratio (eoy) x32.5-16.5 -196.9%  
Price / Book Value ratio x7.63.0 252.5%  
Dividend payout %30.70 -184,882.9%   
Avg Mkt Cap Rs m151,84885,379 177.9%   
No. of employees `0003.56.3 55.7%   
Total wages/salary Rs m4,3569,371 46.5%   
Avg. sales/employee Rs Th10,555.56,295.0 167.7%   
Avg. wages/employee Rs Th1,249.91,498.3 83.4%   
Avg. net profit/employee Rs Th1,292.2-1,066.3 -121.2%   
INCOME DATA
Net Sales Rs m36,78639,369 93.4%  
Other income Rs m1,1331,202 94.2%   
Total revenues Rs m37,91940,571 93.5%   
Gross profit Rs m6,04718 33,045.4%  
Depreciation Rs m1691,495 11.3%   
Interest Rs m232,555 0.9%   
Profit before tax Rs m6,989-2,830 -247.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,582 0.0%   
Tax Rs m2,485257 967.0%   
Profit after tax Rs m4,503-6,669 -67.5%  
Gross profit margin %16.40 35,365.7%  
Effective tax rate %35.6-9.1 -391.5%   
Net profit margin %12.2-16.9 -72.3%  
BALANCE SHEET DATA
Current assets Rs m27,61033,796 81.7%   
Current liabilities Rs m8,56926,917 31.8%   
Net working cap to sales %51.817.5 296.2%  
Current ratio x3.21.3 256.6%  
Inventory Days Days6079 75.9%  
Debtors Days Days2789 30.7%  
Net fixed assets Rs m1,05739,664 2.7%   
Share capital Rs m213553 38.4%   
"Free" reserves Rs m19,87327,968 71.1%   
Net worth Rs m20,08628,522 70.4%   
Long term debt Rs m021,731 0.0%   
Total assets Rs m29,40981,620 36.0%  
Interest coverage x311.6-0.1 -289,809.6%   
Debt to equity ratio x00.8 0.0%  
Sales to assets ratio x1.30.5 259.3%   
Return on assets %15.4-5.0 -305.3%  
Return on equity %22.4-23.4 -95.9%  
Return on capital %34.9-7.7 -454.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3699,807 3.8%   
Fx outflow Rs m4,9181,789 275.0%   
Net fx Rs m-4,5498,019 -56.7%   
CASH FLOW
From Operations Rs m4,991684 729.3%  
From Investments Rs m-2,5706,302 -40.8%  
From Financial Activity Rs m-1,428-7,695 18.6%  
Net Cashflow Rs m993-664 -149.6%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 2.3 343.5%  
FIIs % 0.1 7.7 1.3%  
ADR/GDR % 0.0 0.1 -  
Free float % 17.1 15.4 111.0%  
Shareholders   18,270 67,757 27.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  CADILA HEALTHCARE  NOVARTIS  PANACEA BIOTECH  

Compare ABBOTT INDIA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

WOCKHARDT Announces Quarterly Results (3QFY20); Net Profit Up 125.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, WOCKHARDT has posted a net profit of Rs 192 m (up 125.0% YoY). Sales on the other hand came in at Rs 9 bn (down 16.9% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Apr 16, 2021 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - FULFORD INDIA COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS